Innoviva

May 03, 2019

Trelegy swims against the respiratory current

November 22, 2017

Debt becomes a way of life for biotech

September 19, 2017

One chance for Glaxo’s triple

The UK company's triple combo just got US approval, and now the group must meet rising analyst expectations.

September 08, 2017

Upcoming events – GSK’s triple COPD play and data for Xtandi in earlier stage prostate cancer

November 21, 2016

Can Glaxo’s COPD triple play a solo act?

September 21, 2015

ICAAC – Merck & Co scores with non-antibiotic antibacterial

September 09, 2015

Glaxo shoots itself in the foot... again

June 18, 2015

Novartis’s triple push has an unusual target

May 27, 2015

Boehringer opens new front in respiratory price war